INHIBITORS OF MSBA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

The present disclosure is directed to certain functionalized dual substituted arene derivatives (e.g., arenesulfonamide, arenesulfamide, areneoxalamide and areneamide derivatives) of Formula I: and pharmaceutically acceptable salts thereof, wherein X1, X2, Y, Z, G, R1, R2, R3, R4, and R5are as defined herein, which are potent inhibitors of MsbA and may be useful in the treatment of infections caused by any multi-drug resistant (MDR) Gram-negative bacteria. The disclosure is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of infections in which MsbA is involved..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 23. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

RAHEEM IZZAT [VerfasserIn]
BALIBAR CARL J [VerfasserIn]
SKUDLAREK JASON W [VerfasserIn]
LABROLI MARC A [VerfasserIn]
MITCHELL HELEN [VerfasserIn]
TONG LING [VerfasserIn]
FORSTER ASHLEY [VerfasserIn]
HUNTER DAVID N [VerfasserIn]
LI SARAH W [VerfasserIn]
WANG HAO [VerfasserIn]
WU CHENGWEI [VerfasserIn]
BUEVICH ALEXEI [VerfasserIn]
ZHANG LI-KANG [VerfasserIn]
BABAOGLU KERIM [VerfasserIn]
WU ZHE [VerfasserIn]
SHAW ANTHONY W [VerfasserIn]
COOKE ANDREW J [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-23, Last update posted on www.tib.eu: 2024-01-19, Last updated: 2024-01-26

Patentnummer:

WO2023224893

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA01874351X